{"id":"W2789648792","doi":"10.1097/hco.0000000000000518","title":"An update on trials of novel lipid-lowering drugs","year":2018,"lang":"en","type":"review","venue":"Current Opinion in Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"ca_institutions":"St. Thomas Hospital","funders":"AstraZeneca","keywords":"Medicine; Evolocumab; Canakinumab; PCSK9; Kexin; Cholesterylester transfer protein; Proprotein convertase; Population; Cholesterol; Internal medicine; Pharmacology; Coronary artery disease; Clinical trial; Statin; Lipoprotein; Disease; LDL receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.006277833,0.0005001365,0.007440647,0.0005929352,0.0000379829,0.000009109365,0.0002982882,0.0006272609,0.00003389423],"category_scores_gemma":[0.0005654986,0.0003668406,0.002482473,0.0003738652,0.0001438161,0.00004038202,0.00009853877,0.0007871992,0.00005362116],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002293114,"about_ca_system_score_gemma":0.0007241165,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000177561,"about_ca_topic_score_gemma":3.306075e-7,"domain_scores_codex":[0.9949903,0.001231544,0.002066199,0.0008145401,0.0004326466,0.0004647259],"domain_scores_gemma":[0.9970831,0.0002733762,0.0008030594,0.00148929,0.0001402624,0.0002108998],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00006721843,0.0001558852,0.00001414131,0.03193969,0.0004759901,0.000001982397,0.0000329031,0.000005167268,5.478681e-7,0.0002344376,0.001792979,0.965279],"study_design_scores_gemma":[0.00167322,0.0005248821,0.00003404816,0.03003398,0.0005610227,0.0001211171,0.0000115689,0.000004751497,0.000001829961,0.000008711288,0.9667542,0.0002706905],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00004222336,0.9794307,0.000723472,0.00002501745,0.01706176,0.002128166,0.0002235789,0.00004097735,0.0003241154],"genre_scores_gemma":[0.00008390633,0.9867053,0.0001123604,0.00001774376,0.01176589,0.0002854457,0.0009554868,0.00006874875,0.000005106781],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9650084,"threshold_uncertainty_score":0.9998783,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2310107588188999,"score_gpt":0.4738872178933312,"score_spread":0.2428764590744313,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}